Fluorocarbon-Based Blood Substitutes: What Progress?

Chang T.M.S. , Geyer R.P. , eds. Blood substitutes. New York: Marcel Dekker Inc, 1989

NIH Consens Statement. Perioperative red cell transfusion. JAMA 1988; 260: 2200–703.

ONUDI symposium on blood and its derivatives (Macao Dec 1986). Lyon: Fondation Marcel Mérieux ed, 1987.

Chang T.M.S. Red blood cell substitutes: microencapsulated hemoglobin and cross-linked hemoglobin including pyridoxylated polyhemoglobin and conjugated hemoglobin. In: Chang T.M.S. , Geyer R.P. , eds. Blood substitutes, New York: Marcel Dekker Inc, 1989; 11–29.

Hemoglobin-based blood substitutes: further preclinicals. FDC Reports. March 19, 1990: 13.

Riess J.G. Hemocompatible fluorocarbon emulsions. In: Technomics Publ C°, Blood compatible materials and devices: prospectives towards the 21st century. Pa, USA. Lancaster 1991.

Riess J.G. , Le Blanc M. Preparation of perfluorochemical emulsions for biomedical use: principles, materials and methods. In: Lowe KC, ed. Blood substitutes: preparation, physiology and medical applications. Chichester: Ellis-Horwood, 1988; 5: 94–129.

Naito R. , Yokoyama K. Perfluorochemical blood substitutes. Technical Information Series, N°5 and N°7. Osaka, Japan: Green Cross Corp, 1978; 191.

Gould S.A. , Rosen A.I. , Sehgal L.R. Fluosol-DA as a red-cell substitute in acute anemia. New Engl J Med 1986; 314: 1653–6.

Alpha therapeutic's fluosol oxygen transport fluid approved for use in angioplasty. FDC Reports. Jan 8, 1990: 8.

Long D.C. , Long D.M. , Riess J.G. , Follana R. , Burgan A. , Mattrey R.F. Preparation and application of highly concentrated perfluorooctylbromide fluorocarbon emulsions. In: Chang T.M.S. , Geyer R.P. , eds. Blood substitutes. New York: Marcel Dekker Inc, 1989; 441–2.

Long D.M. , Long D.C. , Mattrey R.F. An overview of perfluorooctylbromide. Application as a synthetic oxygen carrier and imaging agent for X-ray, ultrasound and nuclear magnetic resonance. In: Chang T.M.S. , Geyer R.P. , eds. Blood substitutes. New York: Marcel Dekker Inc, 1989; 411–20.

Riess J.G. Post-fluosol progress in fluorocarbon emulsions for in vivo oxygen delivery. In: La Trasf. del Sangue. Proceedings of the International Symposium of Artificial Blood Substitutes, 1987; 32: 316–34.

Riess J.G. Reassessment of criteria for the selection of perfluorochemicals for second generation blood substitutes. Analysis of structure/property relationships. Artif Organs 1984; 8: 44–56.

Mattrey R.F. Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging. Am J Radiol 1989; 152: 247–52.

Long D.M. , Higgins C.B. , Mattrey R.F. , Mitten R.M. , Multer F.K. Is there a time and a place for radiopaque fluorocarbons? In: Banks R.E. , ed. Preparation, properties and industrial applications of organofluorine compounds. Chichester: Ellis Horwood Ltd, 1982; 139–56.

Santini G. , Le Blanc M. , Riess J.G. The reaction of perfluoroalkylcopper compounds with 1-bromo, 1-per-fluoroalkylethuylenes. Tetrahedron 1973; 29: 2411–4.

Jeanneaux F. , Le Blanc M. , Riess J.G. , Yokoyama K. Fluorocarbons as gas carriers for biomedical applications - 1,2-bis(F-butyl)ethene as a candidate O₂/CO₂ carrier for second-generation blood substitutes. Nouv J Chim 1984; 8: 251–7.

Hamai H. , Lacombe C. , Lelièvre J.C. , Le Blanc M. , Riess J.G. Conséquences hémorhéologiques de l'emploi d'é-mulsions de fluorocarbures comme substituts temporaires du sang. Meeting Société Française Hémorhéologie Clinique and Royal Society of Medicine, Paris, March 1988.

Bruneton J.N. , Falewee M.N. , François E. Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide. Radiology 1989; 170: 179–83.

Mattrey R.F. Potential role of perfluorooctylbromide in the detection and characterization of liver lesions with CT. Radiology 1989; 170: 18–20.

Schuberth H.O. , Wretlind A. Intravenous infusion of fat emulsions, phosphatides and emulsifiers. Acta Chir Scand 1961; 278(suppl): 3–12.

Skeie B. , Askanazi J. , Rothkopf M.M. , Rosenbaum S.H. , Kvetan V. , Thomashow B. Intravenous fat emulsions and lung function: A review. Crit Care Med 1988; 16: 183–94.

Teague W.G. , Raj J.U. , Braun D. , Berner M.E. , Clyman R.I. , Bland R.D. Lung vascular effects of lipid infusion in awake lambs. Pedit Res 1987; 22: 714–9.

Hageman J.R. , Hunt C.E. Fat emulsions and lung function. Clin Chest Med 1986; 7: 69.

Lustig R. , McIntosh-Lowe N. , Rose C. Phase I/II study of Fluosol and 100% oxygen breathing as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck. Rad Oncol Biol Phys 1989; 16: 1587–93.

Evans R.G. , Kimler B.F. , Morantz R.A. Phase I-II study of the use of Fluosol-DA 20% as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors. Rad Oncol Biol Phys 1990; 19: 415–20.

Miyamoto K. , Schultz E. , Heath T. Pulmonary intravascular macrophages and hemodynamic effect of liposomes in sheep. J Appl Physiol 1988; 64: 1143–52.